Stocks股票 / Health Care / HIMS
HIMS US listed · USD美股 · 美元
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.Hims & Hers Health, Inc.,以hims名义运营,是一家总部位于旧金山的美国远程医疗公司,通过直接面向消费者的订阅模式提供处方药、非处方药和个人护理产品。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-09-28Earnings财务业绩
next report下次财报 2026-11-02Estimates being cut预期下调
Mixed — beat 1 of last 4 quarters表现不稳 — 近 4 季中 1 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 -85.7%
Financials财务数据
fiscal years财年Leverage杠杆
Debt coming due到期债务
SEC filingsSEC 文件Its filings are available, but they do not break debt down by the year it comes due — every bucket below is unreported.已获取该公司的 SEC 文件,但文件中未按到期年度拆分债务 —— 以下各区间均未披露。
Not every company reports a year-by-year schedule. Nothing is being estimated in its place.并非所有公司都会披露逐年到期安排;此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前,现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前,已披露事实与现金流情景保持分离。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Flow:资金流向: $14M premium traded; 0% 0DTE; 43 fresh positions; P/C 0.31; ~leans bullish (direction approx)成交权利金 $14M;0DTE占0%;43个新建仓;看跌看涨比 0.31;≈偏看涨(方向近似)
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$8.3M net (1 buyers, 6 sellers)-$8.3M 净值(1 买家,6 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Casdin Capital | C | Holding持有 | 1.2% | 2026-06-30 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.Hims & Hers Health, Inc.,以hims名义运营,是一家总部位于旧金山的美国远程医疗公司,通过直接面向消费者的订阅模式提供处方药、非处方药和个人护理产品。
- Margin compression despite revenue growth
- Receivables stretch
- Capital intensity rising
Recent news最新动态
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +5.1% | +1.3% |
| 1 Month近1月 | -1.4% | +0.9% |
| 3 Months近3月 | -13.3% | +6.1% |
| 6 Months近6月 | +51.8% | +22.3% |
| Year to date年初至今 | -11.9% | +13.8% |
| 1 Year近1年 | -46.4% | +18.5% |
| 3 Years近3年 | +377.6% | +87.8% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | — | $272M | $527M | $872M | $1.5B | $2.3B |
| EPS每股收益 | — | $-0.58 | $-0.32 | $-0.11 | $0.53 | $0.51 |
| Free cash flow自由现金流 | — | — | — | — | $198M | $57M |
| Gross margin毛利率 | — | 75.2% | 77.6% | 82.0% | 79.5% | 73.8% |
| Net margin净利率 | — | -39.6% | -12.5% | -2.7% | 8.5% | 5.5% |
| FCF margin自由现金流利润率 | — | — | — | — | 13.4% | 2.4% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: inventory & receivables lean vs sales营运资本:存货与应收相对销售保持精简
- Pricing power: strong gross profitability vs peers定价能力:毛利能力强于同业
- Capital discipline: assets +204.5% (aggressive expansion)资本纪律:资产 +204.5%(扩张激进)
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $-0.10 | $-0.07 | -42.9% |
| Mar 2026 | $-0.18 | $0.04 | -550.0% |
| Dec 2025 | $0.07 | $0.02 | +250.0% |
| Sep 2025 | $0.09 | $0.09 | 0.0% |
Estimate revisions预期修正
Dealer positioning map做市商持仓地图
Volatility pricing波动率定价
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Casdin Capital | C | Holding持有 | 1.2% | $24M |
Fund positioning基金持仓概览
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -2.4% | 3 |
| Feb2月 | 67% | +32.3% | 3 |
| Mar3月 | 67% | +18.5% | 3 |
| Apr4月 | 67% | +17.4% | 3 |
| May5月 | 67% | +50.1% | 3 |
| Jun6月 | 67% | +5.8% | 3 |
| Jul7月 | 67% | +7.2% | 3 |
| Aug8月 | 25% | -0.3% | 4 |
| Sep9月 | 75% | +23.3% | 4 |
| Oct10月 | 33% | -4.6% | 3 |
| Nov11月 | 67% | +41.5% | 3 |
| Dec12月 | 33% | -19.2% | 3 |